Prothena Corporation plc ( PRTA) - Stock Earnings
PRTA Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 3, 2026, midnight | — / — | — | — / — | — |
PRTA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -36.5 million USD | 2.4 million USD |
| 2025Q4 | -21.6 million USD | 21000 USD |
| 2026Q1 | 32.7 million USD | 51.1 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
PRTA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -147.0 million USD | 91.4 million USD |
| 2024 | -122.3 million USD | 135.2 million USD |
| 2025 | -244.1 million USD | 9.7 million USD |
| 2026 Est. | — | — |
PRTA
Price: $8.44
52 week price:
Earnings Per Share: -2.81 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: Ireland
Volume: 314000
Ebitda: -47.3 millionMarket Capitalization: 501.5 million